INTESTINAL GANGRENE side effect
What is INTESTINAL GANGRENE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INTESTINAL GANGRENE and Recently Reported Side Effects
INTESTINAL GANGRENE and 15 most Active Side Effect polls
INTESTINAL GANGRENE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with INTESTINAL GANGRENE
BETASERON ELOXATIN FOSAMAX MABTHERA NOVOSEVEN REBIF ZYPREXARebif Side Effects Report #5648197-X
Physician from UNITED STATES reported REBIF problem on Feb 18, 2008. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: intestinal gangrene, . REBIF dosage: unknown. Patient died on 08/25/2006.
Fosamax Side Effects Report #5705863-5
FOSAMAX PLUS D problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 25, 2008. Female patient, 66 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX PLUS D. After drug was administered, patient experienced the following problems/side effects: intestinal gangrene, nausea, . FOSAMAX PLUS D dosage: unknown. Patient recovered.
Zyprexa Side Effects Report #5719206-4
Physician from UNITED KINGDOM reported ZYPREXA problem on Apr 17, 2008. Male patient, 71 years of age, was diagnosed with mania, juvenile arthritis and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: intestinal gangrene, juvenile arthritis, mania, neutropenia, rectal haemorrhage, renal failure acute, . ZYPREXA dosage: 10 MG, UNK. During the same period patient was treated with PREDNISOLONE, OMEPRAZOLE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Novoseven Side Effects Report #5254136-6
NOVOSEVEN problem was reported by a Physician from ISRAEL on Mar 01, 2007. Male patient was diagnosed with haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: intestinal gangrene, . NOVOSEVEN dosage: 7.2 MG, QD. Patient was hospitalized. Patient died on 02/25/2007.
Betaseron Side Effects Report #5450406-7
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Sept 04, 2007. Female patient, 52 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: fall, intestinal gangrene, osteomyelitis, pelvic fracture, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
Betaseron Side Effects Report #5407757-1
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 52 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: fall, intestinal gangrene, osteomyelitis, pelvic fracture, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
Mabthera Side Effects Report #5300487-6
Physician from UNITED KINGDOM reported MABTHERA problem on Apr 10, 2007. Female patient, 64 years of age, was diagnosed with arthritis and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis, intestinal gangrene, sepsis, . MABTHERA dosage: unknown. Patient died.
Eloxatin Side Effects Report #5762943-6
ELOXATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2008. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma, constipation and was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic, diarrhoea, intestinal gangrene, . ELOXATIN dosage: unknown. During the same period patient was treated with SENOKOT, FLUOROURACIL. Patient was hospitalized. Patient recovered.